Literature DB >> 18640690

The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.

Jae-Hyeok Heo1, Kyoung-Min Lee, Sun Ha Paek, Min-Jeong Kim, Jee-Young Lee, Ji-Young Kim, Soo-Young Cho, Yong Hoon Lim, Mi-Ryoung Kim, Soo Yeon Jeong, Beom S Jeon.   

Abstract

The effects of subthalamic nucleus (STN) stimulation on cognition and mood have not been well established. The authors estimated cognitive and mood effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) in patients with Parkinson's disease (PD) at 6 months and 1 year postoperatively. Forty-six patients were recruited from the Movement Disorder Center at Seoul National University Hospital. Neuropsychologic tests were performed three times, before, 6 months after, and 1 year after surgery. Mean patient age was 58 and mean education duration 8 years. Eighteen of the 46 patients were men. The instruments used for assessing cognitive functions were; the Mini-Mental Status Examination (MMSE), the Trail Making Test (TMT), the Korean Boston Naming Test (K-BNT), the Rey-Kim Memory Battery, the Grooved pegboard test, the Stroop test, a fluency test, the Wisconsin Card Sorting test (WCST), and the Beck depression inventory (BDI). Of these tests, the verbal memory test, the Stroop test, and the fluency test showed statistically significant changes. The verbal memory test using the Rey-Kim memory battery showed a decline in delayed recall and recognition at 6 months and 1 year postoperatively, whereas nonverbal memory showed no meaningful change. In terms of frontal lobe function tests, Stroop test and fluency test findings were found to be aggravated at 6 months and this continued at 1 year postoperatively. Previous studies have consistently reported a reduction in verbal fluency and improvements in self-reported symptoms of depression after STN DBS. However, in the present study, Beck depression inventory (B.D.I.) was not significantly changed. Other tests, namely, MMSE, TMT, K-BNT, Grooved pegboard test, and the WCST also failed to show significant changes. Of the baseline characteristics, age at onset, number of years in full-time education, and L-dopa equivalent dosage were found to be correlated with a postoperative decline in neuropsychological test results. The correlation of motor improvement and cognitive deterioration was not significant, which suggests that the stimulation effect is rather confined to the motor-related part in the STN. In conclusion, bilateral STN DBS in Parkinson's disease did not lead to a significant global deterioration in cognitive function. However, our findings suggest that it has minor detrimental long-term impacts on memory and frontal lobe function.

Entities:  

Mesh:

Year:  2008        PMID: 18640690     DOI: 10.1016/j.jns.2008.06.010

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  37 in total

1.  Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Han-Joon Kim; Beom S Jeon; Sun Ha Paek; Kyoung-Min Lee; Ji-Young Kim; Jee-Young Lee; Hee Jin Kim; Ji Young Yun; Young Eun Kim; Hui-Jun Yang; Gwanhee Ehm
Journal:  J Neurol       Date:  2014-04-01       Impact factor: 4.849

2.  Deep brain stimulation and cognitive decline in Parkinson's disease: The predictive value of electroencephalography.

Authors:  A Markser; Franziska Maier; C J Lewis; T A Dembek; D Pedrosa; C Eggers; L Timmermann; E Kalbe; G R Fink; Lothar Burghaus
Journal:  J Neurol       Date:  2015-07-11       Impact factor: 4.849

Review 3.  Influence of deep brain stimulation of the subthalamic nucleus on cognitive function in patients with Parkinson's disease.

Authors:  Bin Wu; Lu Han; Bo-Min Sun; Xiao-Wu Hu; Xiao-Ping Wang
Journal:  Neurosci Bull       Date:  2013-12-12       Impact factor: 5.203

Review 4.  Psychiatric and Cognitive Effects of Deep Brain Stimulation for Parkinson's Disease.

Authors:  Adam Nassery; Christina A Palmese; Harini Sarva; Mark Groves; Joan Miravite; Brian Harris Kopell
Journal:  Curr Neurol Neurosci Rep       Date:  2016-10       Impact factor: 5.081

Review 5.  Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: A Meta-Analysis of Mood Effects.

Authors:  Tomas Cartmill; David Skvarc; Richard Bittar; Jane McGillivray; Michael Berk; Linda K Byrne
Journal:  Neuropsychol Rev       Date:  2021-02-19       Impact factor: 7.444

6.  Evidence of improved immediate verbal memory and diminished category fluency following STN-DBS in Chinese-Cantonese patients with idiopathic Parkinson's disease.

Authors:  Venus Tang; Cannon X L Zhu; Danny Chan; Claire Lau; Anne Chan; Vincent Mok; Jonas Yeung; Wai Sang Poon
Journal:  Neurol Sci       Date:  2015-02-24       Impact factor: 3.307

7.  Initial cognitive dip after subthalamic deep brain stimulation in Parkinson disease.

Authors:  Han-Joon Kim; Beom S Jeon; Ji Young Yun; Young Eun Kim; Hui-Jun Yang; Sun Ha Paek
Journal:  J Neurol       Date:  2013-05-17       Impact factor: 4.849

Review 8.  Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson's Disease: A Meta-Analysis.

Authors:  Hannah L Combs; Bradley S Folley; David T R Berry; Suzanne C Segerstrom; Dong Y Han; Amelia J Anderson-Mooney; Brittany D Walls; Craig van Horne
Journal:  Neuropsychol Rev       Date:  2015-10-12       Impact factor: 7.444

9.  A human prefrontal-subthalamic circuit for cognitive control.

Authors:  Ryan Kelley; Oliver Flouty; Eric B Emmons; Youngcho Kim; Johnathan Kingyon; Jan R Wessel; Hiroyuki Oya; Jeremy D Greenlee; Nandakumar S Narayanan
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

10.  Neuropsychological predictors of patient-reported cognitive decline after deep brain stimulation in Parkinson's disease.

Authors:  Kelly A Mills; Kristyn Donohue; Aathman Swaminathan; Jeannie-Marie Leoutsakos; Gwenn Smith; Jason Brandt
Journal:  J Clin Exp Neuropsychol       Date:  2018-10-08       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.